国际皮肤性病学杂志    2004 30 (3): 188-190   ISSN: 2096-5540  CN: 32-1880/R   白念珠菌系统性感染中白念珠菌相关抗原检测的意义 宋秋荷, 王鲁 第三军医大学西南医院皮肤科 重庆 400038 收稿日期 2003-08-09  修回日期 null  网络版发布日期 null 参考文献  [1] Calderone RA, Fonzi WA. Virulence factors of Candida albicans.Trends Microbiol, 2001, 9:327-335. [2] Moter A, Gobel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods, 2000,41:85-112. [3] Marot-Leblond A, Grimaud L, Nail S, et al. New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol, 2000,38:61-67. [4] Persat F, Topenot R, Piens MA, et al. Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis.Mycoses, 2002, 45:455-460. [5] Han Y, Morrison RP, Cutler JE. A vaccine and monoclonal antibodies that enhance nouse resistance to Candida albicans vaginal infection. Infect Immun, 1998, 66:5771-5776. [6] Bromuro C, Torosantucci A, Chiani P, et al. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Infect Immun, 2002, 70:5462-5470. [7] Forsyth CB, Mathews HL. Lymphocyte adhesion to Candida albicans.Infect Immun, 2002, 70:517-527. [8] Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol, 2000,38:147. [9] Obayashi T, Yoshida M, Mori T, et al. Plasma (1-＞ 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 1995, 345:17-20. [10] Sundstrom P, Jensen J, Balish E. Hnmoral and cellular imnune responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J Infect Dis, 1994, 170:390. [11] Sugiyama Y, Nakashima S, Mirbod F, et al. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol, 1999, 37:61-67. [12] Leidich SD, Ibrahim AS, Fu Y,et al. Cloning andi disruption of caPLBl, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem, 1998, 273:26078-26086. [13] Bennett DE, McCreary CE, Coleman DC. Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans. Microbiology, 1998, 144:55-72. [14] Kanoh H, Nakashima S, Zhao Y, et al. Molecular cloning of a gene encoding phospholipase D from the pathogenic and dimorphic fungus,Candida albicans. Biochim Biophys Acta, 1998, 1398:359-364. [15] Kothavade R J, Panthaki MH. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol, 1998, 47:99-102. [16] Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates ith reference to the sources of strains. Mycoses, 2002, 45:160-165. [17] De Bemardis F, Sullivan PA, Cassone A. Aspartyl proteinases of Candida albieans and their role in pathogenicity. Med Mycol, 2001,39:303-313. [18] Sandini S, Melchionna R, Arancia S, et al. Generation of a highly immunogenic recombinant enolase of the human opportunistic pathogen Candida albicans. Biotechnol Appl Biochem, 1999, 29:223. 通讯作者: